Patient & Survivor Care
From the Journals
Why a New Inhalable Lung Cancer Treatment Is So Promising
A new study shows how exosomes can help treat lung cancer.
Conference Coverage
QOL Not Harmed With Add-On Pembrolizumab in Cervical Cancer
New analyses bring the “voices of the patients from this large phase 3 study.”
Conference Coverage
RUBY: ‘A Huge Win’ for Patients With Advanced or Recurrent Endometrial Cancer
The combination of the PD-1 inhibitor dostarlimab and chemotherapy prolonged life by more than 1 year, compared with chemotherapy alone.
Feature
Combining Targeted Drugs and Radiation in Breast Cancer: What’s Safe?
What is known and unknown about combining radiotherapy and systemic treatments in breast cancer?
Feature
Look Beyond BMI: Metabolic Factors’ Link to Cancer Explained
A snapshot assessment of metabolic syndrome is inadequate to show an association with cancer risk over time, the authors of new research say.
Feature
ASTRO Pushes Return to Direct Supervision in RT: Needed or ‘Babysitting’?
But some radiation oncologists do not agree with the proposal to move back to direct in-person supervision only.
From the Journals
After SABR, 100% Local Control at 1 Year in Kidney Cancer
Researchers investigate the efficacy of SABR in patients with primary renal cell cancer with a single lesion.
Feature
Does worsening metabolic syndrome increase the risk of developing cancer?
Elevated trajectories of metabolic syndrome were associated with an elevated overall cancer risk.
Feature
Higher Prostate Cancer Rates Seen in Black Men, but Advanced Cases Similar to White Men
Pros and cons of establishing different “normal” PSA levels for different races discussed.
Feature
New Cancer Surgical Tech Gets Positive Vote, But Some Cite Safety Concerns
An FDA committee majority voted in support of a new drug-device combination that detects residual cancer, but some are not convinced the benefits...
Feature
Does Exercise Reduce Cancer Risk? It’s Just Not That Simple
What are the cancer types where exercise makes a difference?